Clinical Study to Compare the Pharmacokinetics and Safety of Ramucirumab Injection With Cyramza ® in Healthy Male Volunteers

Clinical trial NCT05800418 · COMPLETED

Trial details

NCT number: NCT05800418
Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Gastric Cancer Non-small Cell Lung Cancer Colo-rectal Cancer

Start date: 2019-11-04
Primary completion: 2020-02-18
Enrollment: 88

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.